Get Live Data

Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners
Tribe Technology set to deliver healthy pipeline of orders from Tier-One minersView Video
Andrada Mining acquisition elevates the miner to emerging mid-tier status
Andrada Mining acquisition elevates the miner to emerging mid-tier statusView Video

Latest Share Chat

  2. Share Prices
  3. Glaxosmithkline Share Price
  4. Glaxosmithkline Share News
  5. UK Dividends Calendar - Week Ahead

Pin to quick picksGlaxosmithkline Share News (GSK)

Glaxosmithkline Information

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,529.50
Bid: 1,531.50
Ask: 1,532.00
Change: 3.50 (0.23%)
Spread: 0.50 (0.033%)
Open: 1,537.00
High: 1,541.50
Low: 1,523.00
Prev. Close: 1,526.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Dividends Calendar - Week Ahead

Mon, 12th May 2014 05:10

UK Dividends Calendar 
Monday, May 12 
NorthamberPayment date 2014 dividend
Delphi AutomotiveEx-dividend date 2014
Laura AshleyPayment date 2013 dividend
Tuesday, May 13 
DCG Iris LimitedPayment date 2013 dividend
Wednesday, May 14 
J SainsburyEx-dividend date 2013
Sage GroupEx-dividend date 2014
SercoPayment date 2013 dividend
Air PartnerEx-dividend date 2013
Morgan Advanced MaterialsEx-dividend date 2013
BarclaysEx-dividend date 2014
St IvesPayment date 2014 dividend
Aberdeen Asset ManagementEx-dividend date 2014
AlentEx-dividend date 2013
European Assets TrustEx-dividend date 2014
Fidessa GroupEx-dividend date 2013
GlaxoSmithKlineEx-dividend date 2014
Kingfisher GroupEx-dividend date 2013
Standard CharteredEx-dividend date 2013
CarillionEx-dividend date 2013
InmarsatEx-dividend date 2013
Management Consulting GroupEx-dividend date 2013
Medicx FundEx-dividend date 2014
Numis CorporationEx-dividend date 2014
Royal Dutch ShellEx-dividend date 2014
Glencore XstrataEx-dividend date 2013
Picton Property IncomeEx-dividend date 2014
BlackRock Smaller Companies TrustEx-dividend date 2013
British & American Investment TrustEx-dividend date 2013
British Polythene IndustriesEx-dividend date 2013
RegenersisEx-dividend date 2013
Fidessa GroupSpecial dividend payment date
MallettSpecial dividend payment date
Thursday, May 15 
LadbrokesPayment date 2013 dividend
MelrosePayment date 2013 dividend
BlackRock World Mining TrustPayment date 2013 dividend
Melrose IndustriesPayment date 2013 dividend
Noble CorporationPayment date 2013 dividend
Tullett PrebonPayment date 2013 dividend
Photo-Me InternationalSpecial dividend payment date
Friday, May 16 
J SainsburyRecord date 2013 dividend
SageRecord date 2014 dividend
Kier GroupPayment date 2014 dividend
Man GroupPayment date 2014 dividend
HG Capital TrustPayment date 2013 dividend
AvivaPayment date 2013 dividend
DevroPayment date 2013 dividend
Novae GroupPayment date 2013 dividend
Murray International TrustPayment date 2013 dividend
Aberdeen Asian Income FundPayment date 2013 dividend
Arbuthnot Banking GroupPayment date 2013 dividend
ARM HoldingsPayment date 2013 dividend
Carrs Milling IndustriesPayment date 2014 dividend
T ClarkePayment date 2013 dividend
Drax GroupPayment date 2013 dividend
Johnson Service GroupPayment date 2013 dividend
Millennium & Copthorne HotelsPayment date 2013 dividend
Jupiter Dividend & Growth TrustPayment date 2014 dividend
St James's PlacePayment date 2013 dividend
Millennium & Copthorne HotelsSpecial dividend payment date
Novae GroupSpecial dividend payment date
  
Copyright 2014 Alliance News Limited. All Rights Reserved.
  

More News
16 Jun 2023 17:01

LONDON MARKET CLOSE: FTSE 100 ends a week of rate decisions higher

(Alliance News) - Stocks in London ended largely higher on Friday, following a busy week centred on the interest rate decisions of three major central banks.

Read more
16 Jun 2023 11:59

GSK cancer drug delay by FDA not "necessarily a red flag"

(Alliance News) - GSK PLC must gain approval for its "centrepiece" cancer drug momelotinib to validate its mergers & acquisitions pipeline but the extension of its review period in the US does not automatically spell trouble, according to analysis from Shore Capital on Friday.

Read more
16 Jun 2023 07:47

FDA extends review period of GSK blood cancer drug momelotinib

(Sharecast News) - GSK said on Friday that the US Food and Drug Administration has extended the review period of its new drug application for momelotinib, which is used to treat a blood cancer called myelofibrosis.

Read more
16 Jun 2023 07:42

IN BRIEF: GSK says FDA extending review period for blood cancer drug

GSK PLC - Brentford, England-based pharmaceutical company - Says US Food & Drug Administration has extended the review period of the new drug application for momelotinib by three months. Extension aims to provide time to review recently submitted data. The extended action date is September 16. Momelotinib uses "novel mechanism of action" to treat myelofibrosis, a rare blood cancer, as well as progressive anaemia which characterises the disease. Myelofibrosis affects approximately 25,000 US patients. The drug is not currently approved in any markets. GSK says it is "confident in the momelotinib NDA and looks forward to working with the FDA as they finalise their review."

Read more
9 Jun 2023 06:53

AstraZeneca hails RSV drug nirsevimab recommendation by FDA committee

(Alliance News) - AstraZeneca PLC on Thursday said that a US Food & Drug Administration committee unanimously recommended its antibody nirsevimab.

Read more
8 Jun 2023 12:09

London "still attractive" place to list, as IPO activity trickles back

(Alliance News) - A recent revival of initial public offerings in London's equity markets is encouraging evidence that the city still holds appeal on the global stage, analysts contended.

Read more
7 Jun 2023 09:22

EU approves its first vaccine for common respiratory virus RSV

June 7 (Reuters) - European regulators have approved the region's first vaccine for respiratory syncytial virus (RSV), which causes thousands of hospitalisations and deaths annually.

Read more
7 Jun 2023 09:10

LONDON MARKET OPEN: Stocks head lower amid global growth fears

(Alliance News) - Stock prices in London opened in the red on Wednesday, as concerns about interest rate hikes and a global economic slowdown damped risk appetite.

Read more
7 Jun 2023 07:59

TOP NEWS: GSK's Arexvy is first EU-approved RSV jab for older adults

(Alliance News) - GSK PLC on Wednesday announced that its RSV vaccine Arexvy has become the first EU-backed vaccine against the respiratory syncytial virus for adults aged 60 and older.

Read more
7 Jun 2023 07:34

GSK gets European approval for RSV vaccine

(Sharecast News) - Pharmaceuticals giant GSK announced on Wednesday that the European Commission has granted authorisation for 'Arexvy' - an adjuvant respiratory syncytial virus (RSV) vaccine - for active immunisation to prevent RSV-caused lower respiratory tract disease (LRTD) in adults 60 and older.

Read more
6 Jun 2023 08:34

US FDA accepts GSK's licence application for cancer treatment Jemperli

(Alliance News) - GSK PLC on Tuesday said the US Food & Drug Administration accepted its supplemental biologics licence application for endometrial cancer treatment dostarlimab, or Jemperli, after it was granted priority review in September.

Read more
6 Jun 2023 07:41

PRESS: Unilever starts search to replace Nils Andersen as chair

(Alliance News) - Unilever PLC has appointed executive search firm Spencer Stuart to find a replacement for Chair Nils Andersen, Bloomberg reported on Monday, citing "people familiar with the situation".

Read more
6 Jun 2023 07:18

US FDA accepts GSK supplemental application for Jemperli cancer drug

(Sharecast News) - GSK said the US Food and Drug Administration (FDA) has accepted a supplemental Biologics License Application for its Jemperli treatment of adults with primary advanced or recurrent endometrial cancer.

Read more
2 Jun 2023 21:42

IN THE KNOW: hVIVO involvement in drug approval should boost interest

(Alliance News) - hVIVO's involvement in the approval of pharmaceutical giant Pfizer's new vaccine Abrysvo should support interest in its services, according to Liberum.

Read more
31 May 2023 23:35

US FDA approves Pfizer's RSV vaccine

May 31 (Reuters) - The U.S. Food and Drug Administration on Wednesday approved Pfizer Inc's respiratory syncytial virus (RSV) vaccine for older adults, making it the second shot against the common respiratory disease that can be fatal for seniors.

Read more
192021222324252627

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.